Myovant Sciences Ltd. Operating Lease, Payments
Myovant Sciences Ltd. reported Operating Lease, Payments of $3.03 million for the 12-month period ending 2022-03-31, per its 10-K filed 2022-05-11.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2022-05-11
- Myovant Sciences Ltd. operating lease, payments for the quarter ending 2020-09-30 was $734.00K, a 46.51% increase year-over-year.
- Myovant Sciences Ltd. operating lease, payments for the quarter ending 2020-06-30 was $729.00K, a 46.98% increase year-over-year.
- Myovant Sciences Ltd. operating lease, payments for the quarter ending 2020-03-31 was $720.00K.
- Myovant Sciences Ltd. operating lease, payments for the quarter ending 2019-12-31 was $572.00K.
- Myovant Sciences Ltd. operating lease, payments for fiscal 2022 was $3.03M, a 3.03% increase from fiscal 2021.
- Myovant Sciences Ltd. operating lease, payments for fiscal 2021 was $2.94M, a 28.40% increase from fiscal 2020.
- Myovant Sciences Ltd. operating lease, payments for fiscal 2020 was $2.29M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2022-03-31 | $3.03M 10-K · filed 2022-05-11 | |||
| 2021-03-31 | $2.94M 10-K · filed 2022-05-11 | |||
| 2020-09-30 | $734.00K 10-Q · filed 2020-11-12 | $1.46M 10-Q · filed 2020-11-12 | $2.18M derived: sum of 3 quarters · filed 2022-05-11 | $2.75M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-06-30 | $729.00K 10-Q · filed 2020-08-11 | $1.45M derived: sum of 2 quarters · filed 2022-05-11 | $2.02M derived: sum of 3 quarters · filed 2022-05-11 | $2.52M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-03-31 | $720.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-11 | $1.29M derived: sum of 2 quarters · filed 2022-05-11 | $1.79M derived: sum of 3 quarters · filed 2022-05-11 | $2.29M 10-K · filed 2022-05-11 |
| 2019-12-31 | $572.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | $1.07M derived: sum of 2 quarters · filed 2020-11-12 | $1.57M 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $501.00K 10-Q · filed 2020-11-12 | $997.00K 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $496.00K 10-Q · filed 2020-08-11 |